JSF Financial »

Allogene Therapeutics shares owned by JSF Financial

Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by JSF Financial from 13F filings

Historical chart of JSF Financial investment in Allogene Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Allogene Therapeutics held by JSF Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Allogene Therapeutics by JSF Financial

Quarter filed Position value Share count Share price at filing
2026-06-30 $22k 11k 2.08

More positions owned by JSF Financial

Ishares Tr Core S&p500 Etf (IVV)
Capital Group Growth Etf Shs Creat Unit (CGGR)
American Centy Etf Tr Intl Eqt Etf (AVDE)
First Tr Exchange Traded Smid Risng Etf (SDVY)
Ishares Tr Rus Tp200 Gr Etf (IWY)
American Centy Etf Tr Avantis Emgmkt (AVEM)
Ishares Tr Rus Tp200 Vl Etf (IWX)
Apple (AAPL)
Ishares Gold Tr Ishares New (IAU)
Invesco Qqq Tr Unit Ser 1 (QQQ)
State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Lazard Active Etf Tr Intl Dynamic Eqt (IDEQ)
Invesco Exchange Traded Fd T S&p 500 Top 50 (XLG)
NVIDIA Corporation (NVDA)
Bny Mellon Etf Trust Ii Dynamic Value (BKDV)

View all positions for JSF Financial

Top funds holding Allogene Therapeutics

BlackRock
Frazier Life Sciences Management
Pfizer
Tpg Gp A
Sio Capital Management
PRIMECAP Management Company
Vanguard Capital Management
FMR
Citadel Advisors
State Street Corporation
Two Sigma Investments
Geode Capital Management
Goldman Sachs Group
T. Rowe Price Associates
Marshall Wace

View all funds holding Allogene Therapeutics